세계의 두개내 동맥류 시장 규모, 점유율 및 동향 분석 보고서 : 최종 용도별, 유형별, 지역별, 전망 및 예측(2023-2030년)

Global Intracranial Aneurysm Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Type (Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others), By Regional Outlook and Forecast, 2023 - 2030

US $ 3,600 ￦ 5,155,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,187,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,661,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

두개내 동맥류 시장 규모는 예측 기간 동안 CAGR 8.5%로 성장하여 2030년까지 21억 달러에 달할 것으로 예상됩니다.

그러나 신경혈관 시술에 대한 훈련을 받은 중재적 신경방사선과 전문의와 신경외과 전문의 등 신경중재 전문의가 부족하여 동맥류 환자들의 전문적인 진단 및 치료 서비스에 대한 접근성이 제한되고 있습니다. 또한, 신경중재치료에 대한 높은 수요와 전문의 수의 제한으로 인해 동맥류 환자의 초기 평가, 진단 및 치료 시작까지 대기 시간이 길어지고, 예약이 지연되며, 진료 간격이 길어질 수 있습니다. 따라서 신경 중재 전문의의 부족은 시장 성장을 저해하는 요인으로 작용하고 있습니다.

또한, 팬데믹이 한창일 때 전 세계 많은 의료 시설에서 선택적 수술이나 긴급하지 않은 시술을 포함한 일상적인 서비스가 중단되는 사태가 발생했습니다. 그 결과, 동맥류 환자들은 진단, 치료 및 경과 관찰이 지연되어 부작용과 질병 부담 증가로 이어질 수 있었습니다. 또한, 코로나19 감염에 대한 두려움과 의료 환경에서의 노출 가능성에 대한 우려로 많은 환자들이 동맥류 평가 및 치료를 포함한 의료 서비스를 지연시키거나 기피하는 경우가 많았습니다. 이처럼 코로나19의 대유행은 시장에 부정적인 영향을 미쳤습니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요약

• 주요 하이라이트

제3장 시장 개요

• 서론
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장이 해결해야 할 과제
• Porter의 Five Forces 분석

제4장 세계 시장 : 최종 용도별

• 세계의 병원 시장 : 지역별
• 세계의 클리닉 시장 : 지역별
• 세계의 기타 시장 : 지역별

제5장 세계 시장 : 유형별

• 세계의 코일색전술 시장 : 지역별
• 세계의 혈류전환기 시장 : 지역별
• 세계의 Surgical Clipping 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카/중동 및 아프리카
  • 라틴아메리카/중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카/중동 및 아프리카

제7장 기업 개요

• MicroVention, Inc(Terumo Corporation)
• Medtronic PLC
• Stryker Corporation
• MicroPort Scientific Corporation
• Johnson & Johnson
• B Braun Melsungen AG
• Integra LifeSciences Holdings Corporation
• Delta Surgical
• Penumbra, Inc

제8장 두개내 동맥류 시장을 위한 성공 필수 조건

LSH

영문 목차

영문목차

The Global Intracranial Aneurysm Market size is expected to reach $2.1 billion by 2030, rising at a market growth of 8.5% CAGR during the forecast period.

The Asia Pacific region is experiencing significant demographic changes, including population growth, aging, and urbanization. As the population ages, the prevalence of these aneurysms, which increases with age, is also rising. Consequently, the Asia pacific region would acquire nearly 25% of the total market share by 2030. Moreover, rapid urbanization and lifestyle changes contribute to the adoption of risk factors such as smoking, hypertension, and unhealthy diet, further fueling the incidence of these aneurysms in the region.

Increased awareness about the signs, symptoms, and risk factors associated with these aneurysms encourages individuals to seek medical attention and undergo screening tests for early detection and diagnosis. Moreover, public health campaigns, educational programs, and advocacy efforts raise awareness among healthcare professionals, policymakers, and the general population about these aneurysm screening, risk reduction strategies, and early intervention options. Therefore, rising awareness and screening programs are propelling the market's growth. Additionally, risk factors such as hypertension, smoking, atherosclerosis, and certain genetic conditions contribute to the development and progression of these aneurysms. As the prevalence of these risk factors rises globally, the incidence of these aneurysms also increases, leading to a greater demand for diagnostic, preventive, and treatment services. Additionally, the global demographic shift towards an aging population further amplifies the prevalence of risk factors for these aneurysms. Advanced age is associated with an increased likelihood of developing hypertension, atherosclerosis, and other cardiovascular risk factors that predispose individuals to aneurysm formation. Hence, the rising prevalence of risk factors propels the market's growth.

However, the scarcity of neuro-interventional specialists, including interventional neuroradiologists and neurosurgeons trained in neurovascular procedures, restricts access to specialized diagnostic and treatment services for patients with these aneurysms. Moreover, the high demand for neuro-interventional services coupled with a limited number of specialists may result in long wait times, appointment delays, and extended time intervals between initial evaluation, diagnosis, and treatment initiation for patients with these aneurysms. Therefore, a shortage of neuro-interventional specialists is hampering the growth of the market.

Moreover, During the height of the pandemic, many healthcare facilities worldwide experienced disruptions in routine services, including elective surgeries and non-emergency procedures. As a result, patients with these aneurysms faced delays in diagnosis, treatment, and follow-up care, potentially leading to adverse outcomes and increased disease burden. Furthermore, fear of contracting COVID-19 and concerns about potential exposure in healthcare settings led many patients to delay or avoid seeking medical care, including evaluation and treatment for these aneurysms. Thus, the COVID-19 pandemic had a negative impact on the market.

By End-use Analysis

On the basis of end-use, the market is segmented into hospitals, clinics, and others. In 2022, the clinics segment procured a remarkable revenue share in the market. Clinics provide convenient access to specialized care for patients with these aneurysms, particularly those seeking routine follow-up visits, diagnostic evaluations, and non-emergent consultations. Located in community settings and outpatient facilities, clinics offer shorter wait times, flexible scheduling, and closer proximity to patients' homes, making them an attractive option for individuals seeking timely and accessible healthcare services.

By Type Analysis

Based on type, the market is divided into surgical clipping, endovascular coiling, flow diverters, and others. The flow diverters segment recorded the largest revenue share in the market in 2022. Flow diverters are highly effective in treating complex and wide-necked aneurysms. By diverting blood flow from the aneurysm sac, flow diverters promote thrombosis and subsequent occlusion, reducing the risk of rupture and long-term complications. Furthermore, flow diverters can treat a wide range of these aneurysms, including complex, fusiform, and large or giant ones in challenging anatomical locations.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed the maximum revenue share in the market in 2022. North America has a relatively high prevalence of these aneurysms compared to other regions. Increased awareness among healthcare providers and the general population about the aneurysms' risk factors, symptoms, and consequences has led to more frequent diagnosis and treatment, driving demand for related medical services and interventions.

List of Key Companies Profiled

• Medtronic PLC
• Stryker Corporation
• MicroPort Scientific Corporation
• Johnson & Johnson
• MicroVention, Inc. (Terumo Corporation)
• B. Braun Melsungen AG
• Integra LifeSciences Holdings Corporation
• Delta Surgical
• Penumbra, Inc.

Global Intracranial Aneurysm Market Report Segmentation

By End-use

• Hospitals
• Clinics
• Others

By Type

• Endovascular Coiling
• Flow Diverters
• Surgical Clipping
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Intracranial Aneurysm Market, by End-use
  • 1.4.2 Global Intracranial Aneurysm Market, by Type
  • 1.4.3 Global Intracranial Aneurysm Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Intracranial Aneurysm Market by End-use

• 4.1 Global Hospitals Market by Region
• 4.2 Global Clinics Market by Region
• 4.3 Global Others Market by Region

Chapter 5. Global Intracranial Aneurysm Market by Type

• 5.1 Global Endovascular Coiling Market by Region
• 5.2 Global Flow Diverters Market by Region
• 5.3 Global Surgical Clipping Market by Region
• 5.4 Global Others Market by Region

Chapter 6. Global Intracranial Aneurysm Market by Region

• 6.1 North America Intracranial Aneurysm Market
  • 6.1.1 North America Intracranial Aneurysm Market by End-use
    • 6.1.1.1 North America Hospitals Market by Country
    • 6.1.1.2 North America Clinics Market by Country
    • 6.1.1.3 North America Others Market by Country
  • 6.1.2 North America Intracranial Aneurysm Market by Type
    • 6.1.2.1 North America Endovascular Coiling Market by Country
    • 6.1.2.2 North America Flow Diverters Market by Country
    • 6.1.2.3 North America Surgical Clipping Market by Country
    • 6.1.2.4 North America Others Market by Country
  • 6.1.3 North America Intracranial Aneurysm Market by Country
    • 6.1.3.1 US Intracranial Aneurysm Market
      • 6.1.3.1.1 US Intracranial Aneurysm Market by End-use
      • 6.1.3.1.2 US Intracranial Aneurysm Market by Type
    • 6.1.3.2 Canada Intracranial Aneurysm Market
      • 6.1.3.2.1 Canada Intracranial Aneurysm Market by End-use
      • 6.1.3.2.2 Canada Intracranial Aneurysm Market by Type
    • 6.1.3.3 Mexico Intracranial Aneurysm Market
      • 6.1.3.3.1 Mexico Intracranial Aneurysm Market by End-use
      • 6.1.3.3.2 Mexico Intracranial Aneurysm Market by Type
    • 6.1.3.4 Rest of North America Intracranial Aneurysm Market
      • 6.1.3.4.1 Rest of North America Intracranial Aneurysm Market by End-use
      • 6.1.3.4.2 Rest of North America Intracranial Aneurysm Market by Type
• 6.2 Europe Intracranial Aneurysm Market
  • 6.2.1 Europe Intracranial Aneurysm Market by End-use
    • 6.2.1.1 Europe Hospitals Market by Country
    • 6.2.1.2 Europe Clinics Market by Country
    • 6.2.1.3 Europe Others Market by Country
  • 6.2.2 Europe Intracranial Aneurysm Market by Type
    • 6.2.2.1 Europe Endovascular Coiling Market by Country
    • 6.2.2.2 Europe Flow Diverters Market by Country
    • 6.2.2.3 Europe Surgical Clipping Market by Country
    • 6.2.2.4 Europe Others Market by Country
  • 6.2.3 Europe Intracranial Aneurysm Market by Country
    • 6.2.3.1 Germany Intracranial Aneurysm Market
      • 6.2.3.1.1 Germany Intracranial Aneurysm Market by End-use
      • 6.2.3.1.2 Germany Intracranial Aneurysm Market by Type
    • 6.2.3.2 UK Intracranial Aneurysm Market
      • 6.2.3.2.1 UK Intracranial Aneurysm Market by End-use
      • 6.2.3.2.2 UK Intracranial Aneurysm Market by Type
    • 6.2.3.3 France Intracranial Aneurysm Market
      • 6.2.3.3.1 France Intracranial Aneurysm Market by End-use
      • 6.2.3.3.2 France Intracranial Aneurysm Market by Type
    • 6.2.3.4 Russia Intracranial Aneurysm Market
      • 6.2.3.4.1 Russia Intracranial Aneurysm Market by End-use
      • 6.2.3.4.2 Russia Intracranial Aneurysm Market by Type
    • 6.2.3.5 Spain Intracranial Aneurysm Market
      • 6.2.3.5.1 Spain Intracranial Aneurysm Market by End-use
      • 6.2.3.5.2 Spain Intracranial Aneurysm Market by Type
    • 6.2.3.6 Italy Intracranial Aneurysm Market
      • 6.2.3.6.1 Italy Intracranial Aneurysm Market by End-use
      • 6.2.3.6.2 Italy Intracranial Aneurysm Market by Type
    • 6.2.3.7 Rest of Europe Intracranial Aneurysm Market
      • 6.2.3.7.1 Rest of Europe Intracranial Aneurysm Market by End-use
      • 6.2.3.7.2 Rest of Europe Intracranial Aneurysm Market by Type
• 6.3 Asia Pacific Intracranial Aneurysm Market
  • 6.3.1 Asia Pacific Intracranial Aneurysm Market by End-use
    • 6.3.1.1 Asia Pacific Hospitals Market by Country
    • 6.3.1.2 Asia Pacific Clinics Market by Country
    • 6.3.1.3 Asia Pacific Others Market by Country
  • 6.3.2 Asia Pacific Intracranial Aneurysm Market by Type
    • 6.3.2.1 Asia Pacific Endovascular Coiling Market by Country
    • 6.3.2.2 Asia Pacific Flow Diverters Market by Country
    • 6.3.2.3 Asia Pacific Surgical Clipping Market by Country
    • 6.3.2.4 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Intracranial Aneurysm Market by Country
    • 6.3.3.1 China Intracranial Aneurysm Market
      • 6.3.3.1.1 China Intracranial Aneurysm Market by End-use
      • 6.3.3.1.2 China Intracranial Aneurysm Market by Type
    • 6.3.3.2 Japan Intracranial Aneurysm Market
      • 6.3.3.2.1 Japan Intracranial Aneurysm Market by End-use
      • 6.3.3.2.2 Japan Intracranial Aneurysm Market by Type
    • 6.3.3.3 India Intracranial Aneurysm Market
      • 6.3.3.3.1 India Intracranial Aneurysm Market by End-use
      • 6.3.3.3.2 India Intracranial Aneurysm Market by Type
    • 6.3.3.4 South Korea Intracranial Aneurysm Market
      • 6.3.3.4.1 South Korea Intracranial Aneurysm Market by End-use
      • 6.3.3.4.2 South Korea Intracranial Aneurysm Market by Type
    • 6.3.3.5 Singapore Intracranial Aneurysm Market
      • 6.3.3.5.1 Singapore Intracranial Aneurysm Market by End-use
      • 6.3.3.5.2 Singapore Intracranial Aneurysm Market by Type
    • 6.3.3.6 Malaysia Intracranial Aneurysm Market
      • 6.3.3.6.1 Malaysia Intracranial Aneurysm Market by End-use
      • 6.3.3.6.2 Malaysia Intracranial Aneurysm Market by Type
    • 6.3.3.7 Rest of Asia Pacific Intracranial Aneurysm Market
      • 6.3.3.7.1 Rest of Asia Pacific Intracranial Aneurysm Market by End-use
      • 6.3.3.7.2 Rest of Asia Pacific Intracranial Aneurysm Market by Type
• 6.4 LAMEA Intracranial Aneurysm Market
  • 6.4.1 LAMEA Intracranial Aneurysm Market by End-use
    • 6.4.1.1 LAMEA Hospitals Market by Country
    • 6.4.1.2 LAMEA Clinics Market by Country
    • 6.4.1.3 LAMEA Others Market by Country
  • 6.4.2 LAMEA Intracranial Aneurysm Market by Type
    • 6.4.2.1 LAMEA Endovascular Coiling Market by Country
    • 6.4.2.2 LAMEA Flow Diverters Market by Country
    • 6.4.2.3 LAMEA Surgical Clipping Market by Country
    • 6.4.2.4 LAMEA Others Market by Country
  • 6.4.3 LAMEA Intracranial Aneurysm Market by Country
    • 6.4.3.1 Brazil Intracranial Aneurysm Market
      • 6.4.3.1.1 Brazil Intracranial Aneurysm Market by End-use
      • 6.4.3.1.2 Brazil Intracranial Aneurysm Market by Type
    • 6.4.3.2 Argentina Intracranial Aneurysm Market
      • 6.4.3.2.1 Argentina Intracranial Aneurysm Market by End-use
      • 6.4.3.2.2 Argentina Intracranial Aneurysm Market by Type
    • 6.4.3.3 UAE Intracranial Aneurysm Market
      • 6.4.3.3.1 UAE Intracranial Aneurysm Market by End-use
      • 6.4.3.3.2 UAE Intracranial Aneurysm Market by Type
    • 6.4.3.4 Saudi Arabia Intracranial Aneurysm Market
      • 6.4.3.4.1 Saudi Arabia Intracranial Aneurysm Market by End-use
      • 6.4.3.4.2 Saudi Arabia Intracranial Aneurysm Market by Type
    • 6.4.3.5 South Africa Intracranial Aneurysm Market
      • 6.4.3.5.1 South Africa Intracranial Aneurysm Market by End-use
      • 6.4.3.5.2 South Africa Intracranial Aneurysm Market by Type
    • 6.4.3.6 Nigeria Intracranial Aneurysm Market
      • 6.4.3.6.1 Nigeria Intracranial Aneurysm Market by End-use
      • 6.4.3.6.2 Nigeria Intracranial Aneurysm Market by Type
    • 6.4.3.7 Rest of LAMEA Intracranial Aneurysm Market
      • 6.4.3.7.1 Rest of LAMEA Intracranial Aneurysm Market by End-use
      • 6.4.3.7.2 Rest of LAMEA Intracranial Aneurysm Market by Type

Chapter 7. Company Profiles

• 7.1 MicroVention, Inc. (Terumo Corporation)
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expenses
  • 7.1.5 Recent strategies and developments:
    • 7.1.5.1 Trials and Approvals:
• 7.2 Medtronic PLC
  • 7.2.1 Company overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
  • 7.2.5 Recent strategies and developments:
    • 7.2.5.1 Product Launches and Product Expansions:
  • 7.2.6 SWOT Analysis
• 7.3 Stryker Corporation
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental and Regional Analysis
  • 7.3.4 Research & Development Expense
  • 7.3.5 Recent strategies and developments:
    • 7.3.5.1 Product Launches and Product Expansions:
    • 7.3.5.2 Acquisition and Mergers:
  • 7.3.6 SWOT Analysis
• 7.4 MicroPort Scientific Corporation
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental and Regional Analysis
  • 7.4.4 Research & Development Expense
  • 7.4.5 SWOT Analysis
• 7.5 Johnson & Johnson
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Segmental & Regional Analysis
  • 7.5.4 Research & Development Expenses
  • 7.5.5 Recent strategies and developments:
    • 7.5.5.1 Partnerships, Collaborations, and Agreements:
    • 7.5.5.2 Product Launches and Product Expansions:
  • 7.5.6 SWOT Analysis
• 7.6 B. Braun Melsungen AG
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expenses
  • 7.6.5 SWOT Analysis
• 7.7 Integra LifeSciences Holdings Corporation
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Segmental and Regional Analysis
  • 7.7.4 Research & Development Expenses
  • 7.7.5 SWOT Analysis
• 7.8 Delta Surgical
  • 7.8.1 Company Overview
• 7.9 Penumbra, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental and Regional Analysis
  • 7.9.4 Research & Development Expenses

Chapter 8. Winning Imperatives of Intracranial Aneurysm Market

관련자료